In fact, we observed from clinical data that colorectal cancer patients have lower overall survival when the expressions of the NDUFB8, SDHB, COX4I1, and ATP5A genes are low in the tumor, which correspond with the OXPHOS protein levels of the remaining resistant population after oxaliplatin treatment. The gene discussed is COX4I1; the disease is neoplasm.